Humana Inc (HUM) Shares Bought by Cadence Capital Management LLC
Cadence Capital Management LLC lifted its position in shares of Humana Inc (NYSE:HUM) by 3.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,887 shares of the insurance provider’s stock after acquiring an additional 205 shares during the quarter. Cadence Capital Management LLC’s holdings in Humana were worth $1,434,000 at the end of the most recent quarter.
Several other large investors have also recently made changes to their positions in the company. WFG Advisors LP boosted its stake in shares of Humana by 4.5% during the 2nd quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock worth $113,000 after acquiring an additional 20 shares in the last quarter. Financial Advisors Network Inc. lifted its stake in Humana by 3.4% in the 2nd quarter. Financial Advisors Network Inc. now owns 1,413 shares of the insurance provider’s stock valued at $340,000 after buying an additional 46 shares in the last quarter. HL Financial Services LLC lifted its stake in Humana by 0.9% in the 2nd quarter. HL Financial Services LLC now owns 7,963 shares of the insurance provider’s stock valued at $1,916,000 after buying an additional 68 shares in the last quarter. Nordea Investment Management AB lifted its stake in Humana by 1.0% in the 2nd quarter. Nordea Investment Management AB now owns 7,338 shares of the insurance provider’s stock valued at $1,766,000 after buying an additional 74 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. lifted its stake in Humana by 4.6% in the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 2,095 shares of the insurance provider’s stock valued at $504,000 after buying an additional 92 shares in the last quarter. 94.18% of the stock is currently owned by institutional investors and hedge funds.
Shares of Humana Inc (NYSE:HUM) traded down $2.33 on Friday, reaching $258.53. The company’s stock had a trading volume of 1,370,699 shares, compared to its average volume of 1,391,559. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.61 and a quick ratio of 1.61. The firm has a market cap of $36,933.60, a P/E ratio of 22.06, a PEG ratio of 1.78 and a beta of 0.88. Humana Inc has a 52 week low of $186.25 and a 52 week high of $264.56.
Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.27 by $0.12. The company had revenue of $13.28 billion during the quarter, compared to the consensus estimate of $13.41 billion. Humana had a return on equity of 15.99% and a net margin of 3.49%. Humana’s revenue was down 3.0% on a year-over-year basis. During the same period in the previous year, the firm posted $3.18 EPS. research analysts anticipate that Humana Inc will post 11.63 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be issued a $0.40 dividend. The ex-dividend date is Thursday, December 28th. This represents a $1.60 annualized dividend and a yield of 0.62%. Humana’s dividend payout ratio (DPR) is presently 12.59%.
HUM has been the topic of a number of recent research reports. UBS reaffirmed a “neutral” rating and issued a $250.00 target price (up previously from $237.00) on shares of Humana in a research note on Wednesday, August 9th. BidaskClub raised Humana from a “sell” rating to a “hold” rating in a research note on Thursday, August 10th. Credit Suisse Group reduced their target price on Humana from $256.00 to $246.00 and set a “neutral” rating on the stock in a research note on Friday, November 10th. ValuEngine raised Humana from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Finally, BMO Capital Markets initiated coverage on Humana in a research note on Monday, October 16th. They issued an “outperform” rating and a $300.00 target price on the stock. Thirteen research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $252.81.
ILLEGAL ACTIVITY NOTICE: “Humana Inc (HUM) Shares Bought by Cadence Capital Management LLC” was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another website, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this story can be viewed at https://www.watchlistnews.com/humana-inc-hum-shares-bought-by-cadence-capital-management-llc/1741497.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.